ARCHIVES

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

November 18, 2011

Oblimersen Combination Improves CLL Survival

December 28, 2007